Interestingly, non-eosinophilic exacerbations triggered by viral or bacterial infections were observed in patients treated with mepolizumab (147), an anti-IL-5 antibody, suggesting that removal of eosinophils may cause expansion of virus and/or bacteria. This evidence concerns the gene IL5 and bacterial infectious disease.